Construction of Delta Pharma’s $100m plant begins in Mirsarai
Construction has commenced on Delta Pharma's new facility in Mirsarai, with a long-term investment plan of $100 million. The initial phase involves an investment of $43 million.
The construction of a new manufacturing plant for Delta Pharma has officially begun in Mirsarai. The company's associate entities, Delta Life Sciences PLC and Delta API Ltd, have outlined a long-term investment plan totaling $100 million for the project. Approximately $43 million is being allocated for the first phase of development. Production at the facility is projected to commence by 2029.
